Market Research Logo

Hong Kong Pharmaceuticals and Healthcare Report Q4 2017

Hong Kong Pharmaceuticals and Healthcare Report Q4 2017

BMI View: Hong Kong's pharmaceuticals and healthcare sector continues to show potential forunprecedented growth. Apart from its ageing population, the kind of health issues extant in the country, asreported by the Department of Health, will serve as key growth drivers. Though growth potential inpharmaceuticals is limited, healthcare services will play a greater role in ensuring expansion of the sectoras a whole. Developments within pharmaceuticals will be mainly driven by changes to healthcare provisionmodels. For example, the government continues to subsidise citizens who are unable to afford healthcareservices, thus creating increased opportunities for firms in the market.

Headline Expenditure Projections

Pharmaceuticals: HKD9.6bn (USD1.2bn) in 2016 to HKD10.3bn (USD1.3bn) in 2017; +7.1% in localcurrency and 7.2% US dollars terms. Forecast revised due to new data source.

Healthcare: HKD152.4bn (USD19.6bn) in 2016 to HKD163.7bn (USD21.1bn) in 2017; +7.4% in localcurrency and 7.4% in US dollars terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Hong Kong 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hong Kong 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hong Kong 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Hong Kong 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Hong Kong 2015-2021)
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Diverse Opportunities And Inherent Risks
Regulatory Review
Table: Processed Applications
Intellectual Property Issues
Pricing And Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Hong Kong 2011-2015)
Table: Healthcare Personnel (Hong Kong 2011-2016)
Table: Healthcare Activity (Hong Kong 2011-2016)
Research And Development
Clinical Trials
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
CK Life Sciences
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
Sanofi
Wuyi International Pharmaceutical
Demographic Forecast
Table: Population Headline Indicators (Hong Kong 1990-2025)
Table: Key Population Ratios (Hong Kong 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Hong Kong 1990-2025)
Table: Population By Age Group (Hong Kong 1990-2025)
Table: Population By Age Group % (Hong Kong 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report